← Evidence map

ArticleBMC medical imaging2026

Metabolic dysfunction-associated steatotic liver disease is associated with myocardial ischemia in patients with suspected or known coronary artery disease, especially in patients without obstructive coronary artery disease.

Yu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Metabolic dysfunction-associated steatotic liver disease is associated with myocardial ischemia in patients with suspected or known coronary artery disease, especially in patients without obstructive coronary artery disease. | Socratic